SOCIAL RESPONSIBILITY AS THE MISSING ELEMENT IN PHARMACEUTICAL PUBLIC RELATIONS: A DIPLOMATIC PROPOSAL FOR MANDATED DISCLOSURE OF NATURAL PROCREATIVE HYGIENE AND APPROPRIATE-AGE INFORMATION
Pharmaceutical public relations is among the most capital-intensive communication enterprises onearth, capable of placing a single message before much of humanity within days. This essay advances aconstructive observation: the element missing from that machinery is not science, and it is not sincerity— it is completed social responsibility. The industry already operates under mandated disclosure ofadverse information (package inserts, contraindication warnings, tobacco-style labeling precedents),proving that commercial channels can carry truths adverse to commercial interest when the publicinterest requires it. We propose extending this settled principle one step further: as a condition ofmarketing fertility-related and maternal-health products, the industry's communication infrastructurewould carry, verbatim and without editorial framing, brief standardized information on (1) non-patented, non-product fertility-awareness methods collectively termed Natural Procreative Hygiene(NPH), documented in the scholarly record for centuries, and (2) established information onappropriate childbearing ages currently absent from medical standards. The proposal is framedthroughout as an opportunity: the industry possesses the only distribution capital capable of reachingthe world's population at scale, and disclosure completed is trust earned. A further possibility isaddressed: that the industry, or its adjacent technology sector, might assert that it invented thesemethods, or holds patents upon them, and therefore owns the category. The essay shows why such aclaim, if made, strengthens rather than defeats the proposal — and why the underlying knowledge,being prior art of the oldest kind, belongs to no patent office. We argue that this "attention invoice" —the obligation of a channel that profits from public attention to pay for it in public information — is thenatural completion of the industry's own stated ESG commitments, not a constraint upon them.
Authors
- Kasey George (ORCID: https://orcid.org/0009-0005-5487-7435)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-15
- DOI
- https://doi.org/10.5281/zenodo.24236164
- Primary Topic
- Pharmaceutical industry and healthcare
- Type
- preprint